Literature DB >> 16859587

What place for the new biologics in the treatment of necrotising vasculitides.

D Jayne.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16859587

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  2 in total

1.  Infliximab in patients with systemic vasculitis that is difficult to treat: poor outcome and significant adverse effects.

Authors:  Shirish R Sangle; Graham R V Hughes; David P D'Cruz
Journal:  Ann Rheum Dis       Date:  2007-04       Impact factor: 19.103

Review 2.  [Vasculitis. Treatment outcome parameters].

Authors:  P M Aries; A Gause
Journal:  Z Rheumatol       Date:  2009-02       Impact factor: 1.372
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.